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A new square tetranuclear copper complex of formula Cu4(LH)4·4DMF with the dinucleating 
amide ligand N4,N5-bis(4-fluorophenyl)-1H-imidazole-4,5-dicarboxamide (LH3) is reported herein. 
This ligand and the complex have been characterized by elemental analysis, FTIR, NMR, mass 
and UV-visible spectroscopy, as well as magnetic and electrochemical measurements. The single 
crystal X-ray diffraction study showed each Cu centre in a distorted square pyramidal 
environment, the square plane being formed by the extended coordination of two sets 
(N,N and N,O) of donor atoms from pairs of different ligands. The Cu4 unit has a Ci symmetry and 
crystallises in the P  space group in between DMF layers. The electronic spectrum of the complex 
exhibits a d–d transition at 676 nm. The complex also displays mild catecholase activity in DMF 
solution by using 3,5-di-tert-butylcatechol as substrate. Variable temperature magnetic 
measurements reveal an antiferromagnetic interaction between the copper centres with two 
different coupling constants of −143.4 and −169.0 cm−1. DFT calculations made on a single 
Cu4 unit from the crystal structure corroborated the antiferromagnetic coupling, the spin density of 
the lower-energy broken-symmetry state being consistent with an alternating +−+− singlet state 
operating at low temperature. 
 
1. Introduction 
Metal-assisted self-assembly processes constitute successful approaches to the synthesis of well 
defined, aesthetic, supramolecular structures from both biological1–4 and synthetic5–10 origins. Grid 
type complexes of five or six coordinate metal ions from first row transition metals display 
intriguing electronic and magnetic properties.11,12 Electronically and magnetically active self-
assembled metal containing motifs are promising candidates for the next generation of nanoscale 
electronic or spintronic devices.13–15 In particular, square [n × n] and rectangular [m × n] 
grids, m, n ≤ 4, are well documented as supramolecular devices for information storage and 
processing.11,16 Designing of the grid like metal ion arrays is based on well directed coordination 
algorithm providing preferred coordination geometry of the metal ions and the ligand's donor sites. 
The deprotonated form of the amide functionality has good donor properties (either through 
oxygen or nitrogen atom) and can be synthesized easily. Thus, properly designed bis-amide 
ligands may provide suitable conformations to create a donor environment for adequate metals 
leading to square [2 × 2] grid-like structures. Use of amide ligands are advantageous over other 
systems due to reduction in the three-dimensional flexibility of the donor set while prohibiting the 
coordination of two amide groups to the same metal ion.17 
Amides are biologically omnipresent functional groups. Metal–peptide complexes have a 
fascinating chemistry, being addressed by inorganic and biological chemists because of their bio-
mimetic relevance.18–25 Deprotonated form of amide ligands are capable to stabilize high oxidation 
state of metals and the resultant complexes often act as efficient oxidation catalysts.26,27 
Catechol oxidase (CO), a type-III copper protein, catalyses the oxidation of o-diphenol to the 
corresponding quinone,28,29thereafter undergoing autopolymerisation to form melanin, a brown 
coloured pigment. In this way CO protects damaged tissues of plants against pathogens or insects. 
X-ray crystal structure of CO from sweet potato (Ipomoea batatas), determined by T. Klabunde et 
al.,30 reveals a dinuclear, hydroxo-bridged Cu2 site, each copper being coordinated by three 
histidine nitrogen atoms. Therefore, a large number of dinuclear copper complexes31–40 have been 
screened to study its CO activity. In this sense, molecular catalysts having more than two copper 
atoms, however, are very rare. Mazumdar et al. reported41 a series of polymeric CuII complexes and 
their catecholase activities. Therefore, in order to achieve a deeper knowledge concerning the 
exact stereo-electronic requirements for catecholase activity and a better understanding of the 
catalytic process, more different polynuclear copper complexes should be explored. 
In this work we report the synthesis, structure, variable temperature magnetic susceptibility 
measurement and catecholase activity of a new square Cu4 complex with the dinucleating amide 
ligand N4,N5-bis(4-fluorophenyl)-1H-imidazole-4,5-dicarboxamide. Experimental magnetic 
behaviour has been supported by theoretical DFT calculations based on the broken-symmetry 
scheme.42 
2. Experimental section 
2.1 Materials 
All chemicals and reagents were purchased from commercial sources, namely Fluka, Aldrich and 
E. Merck, and used without further purification. HPLC grade DMF was used for spectroscopic 
and electrochemical studies. All solvents were A.R. grade and used as received for synthetic work. 
Tetrabutylammonium perchlorate (TBAP), used for the electrochemical studies, was prepared 
according to the literature.43 
2.2 Physical measurements 
Infrared spectra were recorded as KBr pellets on a Shimadzu IR-Prestige21 spectrometer. 
Electronic spectra were recorded on a Perkin Elmer Lambda 750 Spectrophotometer. Elemental 
analyses were performed on Elementar Vario EL III C, H, N, S & O analyzer. Thermogravimetric 
analysis of the complex was executed in a DTG-60 (Shimadzu Corporation, Japan) from 30 to 800 
°C. Electrochemical measurements of the ligand and complex were recorded in DMF containing 
0.1 M TBAP as supporting electrolyte, using a CHI6003E potentiostat, glassy carbon working 
electrode, Pt wire as a counter electrode and Ag/AgCl non aqueous reference electrode. The 
ferrocene/ferrocenium couple was observed at E0 (ΔEp) = 0.2 V (100 mV) under these 
experimental conditions. 1H (400 MHz) and 13C NMR (100 MHz) spectra of the ligand were 
recorded on a JEOL RESONANCE ECZ 400S spectrophotometer, using Si(CH3)4 as internal 
standard. ESI-MS spectra of the samples were recorded on a JEOL JMS 600 instrument. 
2.3 Synthesis of the ligand 
N4,N5-Bis(4-fluorophenyl)-1H-imidazole-4,5-dicarboxamide (LH3).To 50 mL of a 
dichloromethane solution of imidazole-4,5-dicarboxylic acid (156 mg, 1 mmol), oxaloyl chloride 
(252 mg, 2 mmol) was added and stirred at room temperature for 3 hour in nitrogen atmosphere. 
The excess of oxaloyl chloride was removed in vacuum. A mixture of 4-fluoroaniline (222 mg, 2 
mmol) and triethylamine (303 mg, 3 mmol) was added dropwise at 0 °C under nitrogen 
atmosphere and the reaction mixture stirred at room temperature for 6 hour. The solution was 
neutralized by diluted aqueous solution of NaHCO3. The aqueous phase was extracted with 
dichloromethane (3 × 100 mL). After drying, evaporation of the organic phase produced a white 
solid. The product was crystallized from dichloromethane. Yield: 73%, elemental anal. calc. for 
C17H12N4O2F2 (in %): C, 59.65; H, 3.53; N, 16.37 found: C, 59.40; H, 3.51; N, 16.30. IR (KBr, 
cm−1), see Fig. S1 (ESI†): ν 3352 (imidazole N–H stretching), 3162 (amide N–H stretching), 2833 
(Ar C–H stretching), 1672 (amide C O), 1622 (amide N–H in-plane deformation), 1562, 1521 
1421 (C–N). ESIMS:m/z 365{M + Na}, see Fig. S2 (ESI†). 1H NMR (DMSO-d6, 400 MHz) δ, see 
Fig. S3 (ESI†): 13.64 (s, 1H, NH(imidazole)), 13.19 (s, 1H, NH(amide)), 10.65 (s, 1H, 
NH(amide)), 8.00 (s, 1H, CH(imidazole)), 7.84–7.17 (8H, ArH). 13C NMR (DMSO-d6, 100 
MHz) δ, see Fig. S4 (ESI†): 115.7–115.9 (d, 2JC–F = 23 Hz); 116.2–116.4 (d, 2JC–F = 23 Hz); 121.6, 
123.9, 129.9, 133.3, 134.5, 135.3, 137.4, 156.4, 157.7, 158.2, 160.1, 160.6, 163.1 (Fig. 1).  
 
 Fig. 1 Molecular sketch of LH3.  
2.4 Synthesis of the tetranuclear Cu4(LH)4 complex 
To a 10 mL dichloromethane solution of the ligand LH2 (0.34 g, 1 mmol), Et3N (0.202 g, 2 mmol) 
was added followed by Cu(ClO4)2·6H2O (0.37 g, 1 mmol) dissolved in MeOH (50 mL). The 
reaction mixture was refluxed for 5 hour (the colour of the reaction mixture turned to green within 
five minutes) leading to the precipitation of a green solid. On cooling, the solid product was 
filtered off, washed with methanol (2 × 10 mL) and diethyl ether (2 × 10 mL), and finally dried in 
vacuum. Yield: 67%. Single crystals, suitable for X-ray crystallography, were obtained from a 
DMF solution. Elemental anal. calc. for C68H40N16O8F8Cu4: C, 50.56; H, 2.50; N, 13.87 found: C, 
50.63; H, 2.52; N, 13.63%. IR (KBr, cm−1), see Fig. S5 (ESI†): ν 2802 (Ar C–H stretching), 1661 
(amide C O), 1580, 1541, 1473. UV/vis (DMF): λmax/nm (ε/M−1 cm−1): 308 (36 208), 676 (225). 
2.5 Single crystal X-ray crystallography 
Single crystals of the complex Cu4(LH)4·4DMF were obtained by slow evaporation of the 
corresponding DMF solution. A suitable crystal was selected and mounted in fomblin film on a 
micromount and data were collected on a GV1000 and Atlas diffractometer. The crystal was kept 
at 120(2) K during data collection. Using Olex2,44 the structure was solved with the 
olex2.solve45 structure solution program employing Charge Flipping and refined with the 
ShelXL46 refinement package by means of Least Squares minimisation. The crystal data collection 
and refinement parameters are given in Table 1. 
Table 1 Crystal data and details of the structure determination for Cu4(LH)4·4DMF 
Empirical formula C80H68N20O12F8Cu4 
Formula weight 1907.70 
Crystal system Triclinic 
Crystal size/mm3 0.3267 × 0.1147 × 0.0837 
Space group P  
a/Å 10.1601(8) 
b/Å 12.4693(14) 
c/Å 17.1951(11) 
α/° 91.449(7) 
β/° 98.769(6) 
γ/° 113.892(9) 
Cell volume, Å3 1959.3(3) 
Z 1 
T, K 120(2) 
ρcalc, g cm−3 1.617 
F000 972.0 
μ, mm−1 2.052 
Radiation CuKα (λ = 1.54184) 
2Θ range for data collection/° 7.79–149.224 
Index ranges −12 ≤ h ≤ 9, −15 ≤ k ≤ 15, −18 ≤ l ≤ 21 
Reflection collected 14 052 
Independent reflections 7708 [Rint = 0.0261, Rsigma = 0.0351] 
Data/restraints/parameters 7708/0/563 
Goodness-of-fit on F2 1.028 
Final R indexes [I ≥ 2σ(I)] R1 = 0.0356, wR2 = 0.0920 
Final R indexes [all data] R1 = 0.0433, wR2 = 0.0972 
Largest diff. peak and hole (e Å−3) 0.42/−0.53 
 
 
 
2.6 Computational details 
DFT calculations were performed with the GAUSSIAN09 suite of programs47 using the hybrid 
B3LYP exchange–correlation functional.48 The triple-ζ quality basis set (TZV) proposed by 
Ahlrichs and co-workers has been used for all atoms, including the metallic centres.49 A quadratic 
convergence method has been employed in the self-consistent-field process in order to improve the 
obtaining of the correct broken-symmetry states/energies.50 The approach employed in the 
determination of the J values for polynuclear complexes has been described in detail elsewhere.42 
3. Results and discussion 
3.1 Synthesis 
The ligand LH3 was synthesized following earlier reports for similar compounds.51,52 Since the acid 
dichloride formed as intermediate is highly hygroscopic and tend to hydrolyse to the 
corresponding dicarboxylic acid derivative, the reaction medium should be kept extremely dry. 
The purity of the obtained product was quite good and no further purification by column 
chromatography was required. Instead, crystallization from dichloromethane afforded the pure 
compound. The coordinating efficiency of the deprotonated ligand was clearly observed during the 
reaction course. Yet, the initial yellow colour of the deprotonated ligand solution changed to green 
in five minutes after the addition of the Cu(II) salt (Scheme 1). Since the ligand is poorly soluble in 
methanol, a mixed solvent medium was used for the reaction; thus, the ligand was solubilized in 
dichloromethane and Cu(ClO4)2 in methanol. Relative disposition of the amide functionalities in 
alternated conformation with respect to each other due to internal H-bond formation, makes this 
ligand as a well-suited bridging system to get polynuclear structures. Although the ligand has three 
acidic protons, in order to favour a [2 × 2] grid, two equivalent of base were deliberately used to 
abstract the imidazolic and one of the amidic protons (Scheme 2), thus neutralizing the charge of a 
single metallic ion. This approach successfully led to the formation of a [2 × 2] square grid of 
Cu(II) ions.  
 
 Scheme 1 General reaction scheme for the synthesis of the tetranuclear copper complex Cu4(LH)4.  
 
 
 Scheme 2 Deprotonation of the acidic protons. Coordinating atoms are marked with asterisk.  
Different techniques, described below, have been employed to totally characterize the 
tetranuclear, Cu4 complex. Additionally, a thermogravimetric analysis has also been done, see Fig. 
S6 (ESI†), for the desolvated Cu4(LH)4 species. 
3.2 Single crystal X-ray structure of Cu4(LH)4 
A green-coloured single crystal of the tetranuclear Cu4(LH)4 copper complex was obtained from 
slow evaporation of a dimethylformamide solution of Cu4(LH)4. The molecular structure of the 
complex has been determined by single crystal X-ray diffraction (shown in Fig. 2). Bond lengths 
and angles around the metal centres are presented in Table S1 (ESI†).  
 
 Fig. 2 The ORTEP diagram of the tetranuclear, Ci symmetry, Cu complex Cu4(LH)4·4DMF.  
The tetranuclear complex crystallizes in the triclinic system (P  space group) with four DMF 
molecules. Therefore, the molecular formula of the crystal is Cu4(LH)4·4DMF. Single crystal X-
ray crystallography shows that each copper centre has a [4 + 1] coordination. The actual geometry 
around each metal centre was confirmed from the trigonality index (τ).53 For a five coordination 
system this is given by the relation τ = (β − α)/60, where β and α are the two largest bond angles of 
the coordination centre, τ being 0 for a perfect square-pyramidal geometry and 1 for a perfect 
trigonal-bipyramidal geometry. In our Cu4(LH)4·4DMF complex, the two different Cu1 and Cu2 
centres presented the structural indices τ 0.047 and 0.14, respectively, evidencing just small 
deviations from the square-pyramidal geometry. 
The basal plane of the pyramid is formed by a neutral imidazolic nitrogen atom and a 
deprotonated amidic nitrogen atom belonging to one ligand along with the deprotonated 
imidazolic nitrogen atom and a neutral amidic oxygen atom belonging to another ligand. Thus, a 
N3O set of donor atoms completes the square, basal plane of the square pyramid scaffold. The 
fifth, apical position in the pyramid is completed by a dimethylformamide molecule coordinated 
through its oxygen atom. Note that the two amide functionalities of each ligand coordinates 
differently with Cu(II) ions: one of the amide coordinates through the nitrogen atom (Cu1) and the 
other through the oxygen atom (Cu2). The alternated arrangement of the amide groups with 
respect to the pivotal imidazole ring is probably induced by the intramolecular H-bond (per ligand) 
that is formed between the non-coordinated oxygen atom of one amide group and the NH of the 
other one (Fig. 1), thus resulting in two copper atoms positioned on the same side of the ligand, 
favouring the square shape among other possible supramolecular spatial arrangements. 
Cu–N distances are found to range from 1.974 to 2.000 Å, whereas Cu–O distances for 
equatorial and axial positions range from 2.029 to 2.060 Å and 2.213 to 2.254 Å respectively 
(Table S1, ESI†). cis-Position angles in the basal plane around Cu1 fall in the range 80.80(7) to 
98.51(6)°; similar values were found for Cu2 with values ranging 81.33(7) to 107.34(7)°. On the 
other hand, trans-position angles around Cu1 are 163.44(8) and 176.66(7)°, whereas for Cu2 these 
values are 160.09(7) and 171.96(8)°. All these numbers clearly indicate a greater deviation of the 
Cu2 centre from the square-pyramidal geometry, which is also reflected by the 
corresponding τ values (vide supra). The square spatial arrangement is then also supported by the 
formation of four strong intramolecular NH⋯O and four weak intramolecular CH⋯O hydrogen 
bonds (Table 2). 
Table 2 Geometrical features (Å and °) of hydrogen bondsa 
Donor (D)–
H⋯acceptor (A) 
d(D–
H) 
d(H–
A) d(D–A) 
D–H–
A 
a Owing the Ci symmetry of the tetranuclear unit, each entry is established twice on each 
tetranuclear Cu4(LH)4·4DMF unit in the crystal structure. 
Strong                                                          
N(18)–H(18)⋯O(7) 0.88 1.97 2.810(2) 159.8                                                          
N(43)–
H(43)⋯O(32) 
0.88 1.91 2.769(3) 164.2                                                          
                                                           
Weak                                                          
C(24)–
H(24)⋯O(17) 
0.95 2.21 2.829(3) 122.3                                                          
C(45)–
H(45)⋯O(42) 
0.95 2.26 2.862(3) 120.8                                                          
 
 
 
Interestingly, the coordinated DMF molecules form layers in between interpenetrated units of 
alternate up (the corresponding DMF molecule in apical position presents a relative up disposition) 
and down (the DMF molecule has a relative down disposition) tetranuclear species that are 
sandwiched, with intermolecular Cu1⋯Cu1 (or Cu2⋯Cu2) distances of just 4.187 Å, whereas the 
corresponding crossed intermolecular Cu1⋯Cu2 distances are 7.489 Å. Traversing each DMF 
layer, the shorter interlayer Cu1⋯Cu1 distances are 8.785 Å, and the corresponding crossed 
Cu1⋯Cu2 distances are 8.962 Å (Fig. 3). 
 
 
 Fig. 3 DMF layers created by alternating interpenetrated up/down tetranuclear Cu4(LH)4 units.  
3.3 Electronic spectra 
The UV-vis spectrum of the ligand LH3 was recorded in dimethylformamide in the range 260–600 
nm, whereas for the copper complex the spectrum was recorded in the same solvent up to 1200 nm 
in the NIR region. The only relevant peaks appeared in the ligand at 289 nm and in the metal 
complex at 308 nm, having both almost similar spectral features and being then assigned to an 
intraligand transition in the case of the complex. In the visible region the complex shows a weak 
band at 676 nm (Fig. 4) due to a d–d transition.54–56  
  Fig. 4 Electronic spectrum of Cu4(LH)4 in DMF.  
3.4 Catalytic activity 
Catechol oxidase catalyzes completely the oxidation of catechols (i.e. o-diphenols) to the 
corresponding quinones, and this process is known as catecholase activity57,58 (Fig. 5).  
 
 Fig. 5 Catecholase activity.  
For the catecholase activity 3,5-di-tert-butylcatechol (3,5-DTBC) is the most widely used 
substrate due to its low redox potential for the quinone–catechol couple, which makes it easily 
oxidized to the corresponding quinone, 3,5-di-tert-butylquinone (3,5-DTBQ). Its bulky 
substituents make further oxidation reactions (e.g., ring opening) slower. The detection of the 
oxidation of 3,5-DTBC to the corresponding 3,5-DTBQ can be followed by the development of 
the absorption band at about 400 nm. Therefore, activities and reaction rates can be determined 
using electronic spectroscopy by following the appearance of the characteristic absorption of the 
3,5-di-tert-butyl-o-quinone (3,5-DTBQ). For this purpose a 1 × 10−5 M solution of complex was 
treated with 300 equivalents of 3,5-DTBC under aerobic condition in DMF solution59,60 due to the 
good solubility of the complex and the substrate. After addition of 3,5-DTBC, the increase of the 
absorption at 400 nm, which is indicative of an oxidation to the corresponding quinone (3,5-
DTBQ), indicates catecholase activity (Fig. 6). 
  
 Fig. 6 Increase in the absorbance after the addition of 300 equivalents of 3,5-DTBC to a solution of Cu4(LH)4 complex (10
−5 M) in DMF. 
The spectra were recorded every 10 minutes. 
 
To determine the dependence of the rates on the substrate concentration and various kinetic 
parameters, 1 × 10−5 M solutions of the complex were prepared with increasing concentrations of 
3,5-DTBC (from 20 to 100 eq.) under aerobic conditions. First-order dependence was observed at 
low concentrations of the substrate, whereas saturation kinetics was found at higher concentrations 
of the substrate (Fig. S7a, ESI†). The dependence on the substrate concentration indicates that a 
catalyst–substrate binding is the initial step in the catalytic mechanism. A treatment on the basis of 
Michaelis–Menten approach was, therefore, applied and linearized by means of Lineweaver–Burk 
plot (Fig. S7b, ESI†) to calculate various kinetic parameters such as Michaelis–Menten constant 
(Km = 1.61 × 10−2 M), maximum initial rate (Vmax = 2.174 × 10−4 M h−1) and turn-over number of the 
complex (kcat = 21.74 h−1, calculated by dividing the Vmax value by the complex concentration). 
Several factors, e.g. Cu⋯Cu distance, coordination geometry around the metal center, nature of 
the exogenous bridging ligand, flexibility of the primary ligand, etc. influence the catalytic rate. A 
Cu ⋯Cu distance in the range of 2.9–3.25 Å has been proposed for the best catalytic activity. In 
the crystal structure of the met form of the enzyme, two trigonal pyramidal copper(II) centers are 
bridged by a hydroxo group. But in model systems a better activity for trigonal 
bipyramidal,37 square pyramidal38 or square planar61 Cu(II) centers were reported, i.e., the activity 
can be observed both for four or five coordinate Cu(II) centers. In the 
present Cu4(LH)4·4DMF molecule, all the four Cu(II) centers have nearly square pyramidal 
geometry. Cu⋯Cu distances (sides: 6.167 and 6.174 Å; diagonal: 8.813 Å) are quite long which 
may be the reason for lower catalytic activity. Moreover the rigidity of the bridging ligand may 
also influence the activity. 
3.5 Electrochemical properties 
The electrochemical behaviour of the ligand and complex has been investigated by cyclic 
voltammetry in DMF solution. Cyclic voltammogram of the Cu(II) complex exhibits one 
irreversible reduction of Cu(II) to Cu(I) (Epc) at −0.289 V/(Ag/AgCl) and one ligand-based 
reversible reduction at −1.21 V/(Ag/AgCl), see Fig. S8 (ESI†). 
3.6 Magnetic properties and DFT calculations 
The magnetic properties of the Cu4(LH)4 complex in form of χT vs. T (in blue) and χ vs. T (in red) 
are depicted in Fig. 7. At 300 K, the χT amounts to 1, that is below the expected value for four non 
interacting S = 1/2 copper atoms (χT = 1.5 with g = 2.0). TheχT value decreases to 0.2 on cooling 
to 10 K and remains almost constant until 2 K. On lowering the temperature from 300 K, the χ vs. 
T curve presents a maximum at 170 K. All these facts indicate that a global antiferromagnetic (AF) 
coupling occurs in the sample. The increase at low temperature for χ reveals the presence of some 
monomeric impurities.  
 
 Fig. 7 Temperature dependence of χ (  (red), experimental data;  (red), best fit) and χT (  (blue), experimental data;  (blue), best fit) 
for the crystalline sample of Cu4(LH)4·4DMF. 
 
Due to the Ci symmetry of the Cu4(LH)4 unit, two different Cu–Cu distances are present in the 
Cu4 square. Therefore, two main different magnetic pathways could be considered (ignoring the 
diagonals that actually are expected to be negligible). Consequently, the whole exchange coupling 
could be described by the following spin Hamiltonian: 
 The experimental data were simulated using a least-squares fitting program with a full-matrix 
diagonalization of the exchange coupling. Best fits (solid lines in Fig. 7) were obtained for J1 = 
−143.4 cm−1, J2 = −169.0 cm−1, g = 2.017 and ρ = 0.043, where ρ is the amount of monomeric 
impurity (RχT = 6.21 × 10−5 with RχT = [Σ(χTcalc − χTobs)2/Σ(χTobs)2]). 
Numerous factors have been proposed to correlate the magnitude of the coupling exchange and 
the structure of dinuclear compounds containing the imidazolate bridge.62 The more relevant seems 
to be the influence of the Cu–N–N angle, α,63 that was shown by Massoud et al. to correlate 
linearly with −J.64 Using this correlation for the Cu4(LH)4 complex under study, where the average 
of all the Cu–N–N angles is 175.57°, J should be about −187.5 cm−1, which is a slightly higher 
value than the experimental result (vide supra). Nevertheless, other parameters were identified as 
influencing the coupling exchange62c on these type of complexes, such as the dihedral angle 
between the plane of the magnetic orbitals of the CuII ions, the plane of the imidazolate bridge or 
the increase of the AF (antiferromagnetic) coupling with the increase of the Cu–N–C angle.65 
DFT calculations performed on a unit of the tetranuclear Cu4(LH)4·4DMF complex as found 
in the crystal structure furnished the following values for the magnetic coupling constants, as 
shown in Fig. 8: J1 = −78.3, J2 = −97.6, J3 = −1.42 and J4 = +0.536 cm−1. These values could be 
obtained by calculating five broken-symmetry spin states (without spin projection), namely a 
quintuplet (++++), a triplet (−+++) and three different singlets [(++−−), (+−+−), (+−−+)]. 
Magnetic coupling constants J3 and J4correspond to both diagonals in the square defined by the 
four metallic centres (Fig. 8). As expected, the later values are small enough (compared 
to J1 and J2) to be negligible on the corresponding spin Hamiltonian of the experimental equation 
and this justifies the used Hamiltonian based just on J1 and J2. Therefore, the calculated theoretical 
values agree well with the experimental found values, showing a moderately strong 
antiferromagnetic (AF) coupling between the copper(II) ions. This behaviour could be due to a 
fairly good orbital overlap between the magnetic orbitals of the metallic centres and the 
corresponding orbitals of some ligand atoms (superexchange mechanism), and also probably to the 
absence of mechanisms favouring a ferromagnetic (F) coupling.66 
 
  
Fig. 8 (a) Schematic representation of the Cu4(LH)4·4DMF complex showing the considered magnetic pathways depending on 
its Ci symmetry. (b) Spin density isosurface showing the negative (blue) and positive (grey) isodensity values at 0.0017 e Bohr−3for the 
lowest-energy broken-symmetry singlet state. 
 
The spin density map displayed for the most stable magnetic state (the singlet with alternating 
+−+− spin signs, see Fig. 8) clearly reveals an AF coupling through a delocalized σ exchange 
mechanism (from the dx2–y2 copper(II) orbitals to the sp2 ones of the imidazole N atoms directly 
attached to them) with the most part of the spin density concentrated on the copper(II) ions (as 
they are the magnetic centres) and the neighbour donor atoms. A close inspection on the spin 
density values shows that the magnetic pathway mainly goes through the imidazolyl moiety 
following an inner (N–C–N) pathway. Therefore, it could be pointed out that the magnetic 
interaction pathways are mainly placed, as expected, in the molecular plane. Some selected spin 
densities (in electrons) for this broken-symmetry singlet state are presented in Table S2 (ESI†). 
Despite the good qualitative agreement in sign and magnitude order between the experimental and 
theoretical coupling values, the later are about half of the experimental ones as reported for other 
copper polynuclear complexes.67 This may be due to either intrinsic limitations of the approach 
used in the calculation of the J values for copper atoms or to a high flexibility of the copper 
complex68 that leads to significant geometric differences between high and low temperature 
conformations, which is crucial in the experimental determination but that DFT calculations 
cannot take into account. 
4. Conclusions 
In this work a new bis-amide ligand suitable for metal coordination has been reported. This ligand 
successfully generated a Cisymmetry, [2 × 2] grid, square copper complex. During complexation 
with copper(II) perchlorate, both amide groups behave differently towards the metal, probably due 
to the formation of a strong intramolecular NH⋯O H-bond per ligand. One amide functionality 
coordinates through deprotonated amide nitrogen whereas the other one uses the oxygen atom in 
neutral form. The complex crystallises along interpenetrated Cu4 units separated by layers of 
interwoven DMF molecules, which in turn are coordinated to the copper(II) ions in apical 
positions following an up/down pattern. The title complex shows mild catecholase activity with 
a kcat value of 21.74 h−1. The tetranuclear copper complex showed an antiferromagnetic interaction 
as observed from the lower value of χT and the pattern of χ vs. T plot. Magnetic coupling constants 
calculated theoretically corroborate the experimental findings, showing a good qualitative 
agreement in sign and magnitude. The antiferromagnetic behaviour of the complex may be nicely 
interpreted in terms of a super exchange mechanism due to a strong overlap between the magnetic 
orbital of the metallic centres and the ligands ones, and also probably owing to the absence of 
mechanisms leading to ferromagnetic coupling. Polynuclear copper complexes play important role 
in biological oxidation catalysis. The type of molecule reported in the present study shows mild 
catecholase activity. A systematic variation in the substitutions on ligand to control the electronic 
as well as the magnetic properties may enlight the underlying mechanism. Therefore further 
improvement of the present system will be perused in future accordingly. 
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